Fomepizole Patent Expiration
Fomepizole was first introduced by Par Pharmaceutical Inc
Fomepizole Patents
Given below is the list of patents protecting Fomepizole, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Antizol | US7553863 | Ultrapure 4-methylpyrazole | Jun 30, 2027 | Par Pharm Inc |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Fomepizole Generics
Several generic applications have been filed for Fomepizole. The first generic version for Fomepizole was by American Regent Inc and was approved on Dec 14, 2007. And the latest generic version is by Gland Pharma Ltd and was approved on Jul 6, 2023.
Given below is the list of companies who have filed for Fomepizole generic.
1. GLAND PHARMA LTD
Gland Pharma Ltd has filed for 1 generic for Fomepizole. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.5GM/1.5ML (1GM/ML) | injectable | Prescription | INJECTION | AP | Jul 6, 2023 |
2. NAVINTA LLC
Navinta Llc has filed for 1 generic for Fomepizole. Given below are the details of the strengths of this generic introduced by Navinta Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.5GM/1.5ML (1GM/ML) | injectable | Prescription | INJECTION | AP | Mar 6, 2008 |
3. MYLAN INSTITUTIONAL
Mylan Institutional Llc has filed for 1 generic for Fomepizole. Given below are the details of the strengths of this generic introduced by Mylan Institutional.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.5GM/1.5ML (1GM/ML) | injectable | Discontinued | INJECTION | N/A | Apr 7, 2009 |
4. AM REGENT
American Regent Inc has filed for 1 generic for Fomepizole. Given below are the details of the strengths of this generic introduced by Am Regent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1.5GM/1.5ML (1GM/ML) | injectable | Prescription | INJECTION | AP | Dec 14, 2007 |